For its third fiscal quarter (ending September 30), Scorpio Tankers Inc (NYSE: STNG) has reported a 65% increase in E.P.S. from $2.01 a year ago to $3.31 in the current quarter. For the latest four […]
Pfizer Inc (NYSE: PFE) has reported E.P.S. of $0.79 for its third fiscal quarter (ending September 30) versus $-0.42 for the same period a year ago — a decline of -288%. E.P.S. were $0.76 for […]
Meaningful negative changes in fundamentals have recently occurred for PBF Energy Inc (NYSE: PBF): the consensus estimate for December, 2024 decreased significantly, significant quarterly earnings deceleration occurred, and the consensus estimate for December, 2025 decreased […]
For its third fiscal quarter (ending September 30), MSCI Inc (NYSE: MSCI) has reported a 9% increase in E.P.S. from $3.28 a year ago to $3.58 in the current quarter. E.P.S. were $15.28 for the […]
Leidos Holdings Inc (NYSE: LDOS) has reported E.P.S. of $2.72 for its third fiscal quarter (ending September 30) versus $-2.91 for the same period a year ago — a decline of -193%. E.P.S. were $8.86 […]
For its third fiscal quarter (ending September 30), IDEX Corp (NYSE: IEX) has reported a -43% decline in E.P.S. from $2.76 a year ago to $1.57 in the current quarter. E.P.S. were $6.46 for the […]
First Foundation Inc (NYSE: FFWM) has reported a loss for its third fiscal quarter (ending September 30) of $-1.23 versus $0.04 for the same period a year ago — a decline of -3175%. For the […]
Enterprise Products Partners LP (NYSE: EPD) has reported earnings for its third fiscal quarter (ending September 30) of $0.65 versus $0.60 for the same period a year ago — an increase of 8%. For the […]
Eagle Materials Inc (NYSE: EXP) has reported earnings for its second fiscal quarter (ending September 30) of $4.29 versus $4.29 for the same period a year ago — flat performance. For the latest four quarters […]
Douglas Dynamics Inc (NYSE: PLOW) stock closed at $22.97 on 10/29/24 after a major decline of -11.9%. Moreover, trading volume in this decline was exceptionally high at 437% of normal. Relative to the market the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research